1-3 of 3
Jeanine Walenga, Ph.D.
Close
Sort by
Journal Articles

Functional Microparticles Are up Regulated in Patients with Anti-Heparin/Platelet Factor 4 Antibodies: A Potential Mechanism of Thrombogenesis in the Heparin-Induced Thrombocytopenia Syndrome.

Josephine Cunanan, MD, Michelle Kujawski, Ph.D., He Zhu, M.D., Margaret Prechel, Ph.D., Jeanine Walenga, Ph.D., Debra Hoppensteadt, Ph.D., Jawed Fareed, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 2105.
https://doi.org/10.1182/blood.V110.11.2105.2105
Published: 2007
Journal Articles

Methodologic Variations in the Determinations of Anti-Platelet Factor 4-Heparin Antibodies in Patients Suspected of Having Heparin Induced Thrombocytopenia: Diagnostic and Prognostic Implications.

Jawed Fareed, PhD, Margaret Prechel, Ph.D., Michelle Kujawski, Ph.D., He Zhu, Ph.D., Jeanine Walenga, Ph.D., Debra Hoppensteadt, Ph.D., Josephine Cunanan, M.D., Renu Saxena, M.D.
Journal: Blood
Blood (2007) 110 (11): 3206.
https://doi.org/10.1182/blood.V110.11.3206.3206
Published: 2007
Journal Articles

A Unique Biomarker Is Associated with the Prevalence of Functional Heparin Induced Thrombocytopenia (HIT) Associated Antibodies: Results from Proteomic (ProteinChip Array) Profiling of ELISA Positive HIT Plasma Samples.

Michelle R. Kujawski, PhD, Margaret Prechel, Ph.D., He Zhu, M.D., Jeanine Walenga, Ph.D., Debra Hoppensteadt, Ph.D., Josephine Cunanan, M.D., Cafer Adiguzel, M.D., Jawed Fareed, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 3205.
https://doi.org/10.1182/blood.V110.11.3205.3205
Published: 2007